Ardelyx Inc reports results for the quarter ended December 31 - Earnings Summary

• Ardelyx Inc ARDX.OQ reported quarterly adjusted earnings of 2 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of nine analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -5 cents to 4 cents per share.

• Revenue rose 237.9% to $116.13 million from a year ago; analysts expected $109.94 million.

• Ardelyx Inc's reported EPS for the quarter was 2 cents​.

• The company reported quarterly net income of $4.65 million.

• Ardelyx Inc shares had risen by 25.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1,503% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Ardelyx Inc is $10.50

This summary was machine generated from LSEG data February 20 at 02:45 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)